Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C (1976). „Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group” (angol nyelven). Br J Haematol33 (4), 451–8. o. DOI:10.1111/j.1365-2141.1976.tb03563.x. PMID188440.
Vardiman JW, Thiele J, Arber DA, "et al." (2009. July). „The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.” (angol nyelven). Blood.114 (5), 937-51.. o. DOI:10.1182/blood-2009-03-209262. PMID19357394.
Irons RD, Chen Y, Wang X, Ryder J, Kerzic PJ. (2013. October). „Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease.” (angol nyelven). Genes Chromosomes Cancer.52 (10), 887-94. o. DOI:10.1002/gcc.22084. PMID23840003.
Bizzozero O, Johnson K, Ciocco A (1966). „Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. I. Distribution, incidence and appearance time” (angol nyelven). N Engl J Med274 (20), 1095–101. o. DOI:10.1056/NEJM196605192742001. PMID5932020.
Sandler DP, Shore DL, Anderson JR, et al. (1993. December). „Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.”. J Natl Cancer Inst.85 (24), 1994-2003. o. DOI:10.1093/jnci/85.24.1994. PMID8246285.
Varadarajan R, Licht AS, Hyland AJ, et al. (2012. March). „Smoking adversely affects survival in acute myeloid leukemia patients.”. Int J Cancer.130 (6), 1451-8. o. DOI:10.1002/ijc.26151. PMID21520043.
Shu XO, Ross JA, Pendergrass TW, et al. (1996. January). „Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study.”. J Natl Cancer Inst.88 (1), 24-31. o. DOI:10.1093/jnci/88.1.24. PMID8847721.
Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. (2002. July). „The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.” (angol nyelven). Nat Med.8 (7), 743-50. o. DOI:10.1038/nm726. PMID12091906.
Lo-Coco F, Avvisati G, et al. (2013. July). „Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.” (angol nyelven). N Engl J Med.369 (2), 111-21. o. DOI:10.1056/NEJMoa1300874. PMID23841729.
Ley TJ, Mardis ER, Ding L, et al. (2008. November). „DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.” (angol nyelven). Nature.456 (7218), 66-72. o. DOI:10.1038/nature07485. PMID18987736.
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD; European LeukemiaNet. (2010. January). „Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.” (angol nyelven). Blood.115 (3), 453-74. o. DOI:10.1182/blood-2009-07-235358. PMID19880497.
Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N. (2006. January). „Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.” (angol nyelven). Br J Haematol.132 (2), 162-7. o. DOI:10.10.1111/j.1365-2141.2005.05853.x. PMID16398650.
Craig FE, Foon KA. (2008. April). „Flow cytometric immunophenotyping for hematologic neoplasms.” (angol nyelven). Blood.111 (8), 3941-67. o. DOI:10.1182/blood-2007-11-1205358. PMID18198345.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD. (2007. June). „Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.” (angol nyelven). Br J Haematol.137 (5), 387-400. o. DOI:10.1111/j.1365-2141.2007.06566.x. PMID17488484.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2002. July). „Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.” (angol nyelven). Blood.100 (1), 59-66. o. DOI:10.1182/blood.V100.1.59. PMID12070009.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2005. November). „No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.” (angol nyelven). Blood.106 (10), 3658-65. o. DOI:10.1182/blood-2005-03-1323. PMID16076872.
Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK. (2009. November). „Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.” (angol nyelven). Ann Hematol.88 (11), 1089-97. o. DOI:10.1007/s00277-009-0733-7. PMID19296110.
Ostronoff F, Estey E. (2013. September). „The role of quizartinib in the treatment of acute myeloid leukemia.” (angol nyelven). Expert Opin Investig Drugs.. DOI:110.1517/13543784.2013.842973. PMID24070241.
Paschka P, Marcucci G, Ruppert AS, Mrózek K, Chen H, Kittles RA, Vukosavljevic T, Perrotti D, Vardiman JW, Carroll AJ, Kolitz JE, Larson RA, Bloomfield CD; Cancer and Leukemia Group B. (2006. August). „Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.” (angol nyelven). J Clin Oncol.24 (24), 3904-11. o. DOI:10.1200/JCO.2006.06.9500. PMID16921041.
Inoue D, Maruoka H, Takahashi T. (2010. August). „Clinical analysis and optimization of postremission therapy for acute myeloid leukemia patients with minimal residual disease as determined by flow cytometry.” (angol nyelven). Mediterr J Hematol Infect Dis.2 (2), e2010020. o. DOI:10.4084/MJHID.2010.020. PMID21415971.
Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z. (2012. August). „How to manage acute promyelocytic leukemia.” (angol nyelven). Leukemia.26 (8), 1743-51. o. DOI:10.1038/leu.2012.57. PMID22422168.
Lengfelder E, Hofmann WK, Nowak D. (2012. March). „Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.” (angol nyelven). Leukemia.26 (3), 433-42. o. DOI:10.1038/leu.2011.245. PMID22422168.
Wang ZY, Chen Z. (2008. March). „Acute promyelocytic leukemia: from highly fatal to highly curable.” (angol nyelven). Blood.111 (5), 2505-15. o. DOI:10.1182/blood-2007-07-102798. PMID18299451.
Grimwade D, Mistry AR, Solomon E, Guidez F. (2010). „Acute promyelocytic leukemia: a paradigm for differentiation therapy.” (angol nyelven). Cancer Treat Res.145, 219-35. o. DOI:10.1007/978-0-387-69259-3_13. PMID20306254.
Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM, Tallman MS. (2011. August). „Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.” (angol nyelven). Blood.118 (5), 1248-54. o. DOI:10.1182/blood-2011-04-346437. PMID21653939.
Park Kwaan HC, Cull EH. (2014. March). „The coagulopathy in acute promyelocytic leukaemia - What have we learned in the past twenty years.” (angol nyelven). Best Pract Res Clin Haematol.27 (1), 11-18. o. DOI:10.1016/j.beha.2014.04.005. PMID24907013.
Yanada M, Matsuo K, Emi N, Naoe T. (2005. April). „Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.” (angol nyelven). Cancer.103 (8), 1652-8. o. DOI:10.1002/cncr.20945. PMID15742336.
Koreth J, Schlenk R, et al. (2009. June). „Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.” (angol nyelven). JAMA.301 (22), 2349-61. o. DOI:10.1001/jama.2009.813. PMID19509382.
Shapira T, Pereg D, Lishner M. (2008. September). „How I treat acute and chronic leukemia in pregnancy.” (angol nyelven). Blood Rev.22 (5), 247-59. o. DOI:10.1016/j.blre.2008.03.006. PMID18472198.
Cardonick E, Iacobucci A. (2004. May). „Use of chemotherapy during human pregnancy.” (angol nyelven). Lancet Oncol.5 (5), 283-91. o. DOI:10.1016/S1470-2045(04)01466-4. PMID15120665.
Thol F, Schlenk RF. (2014. May). „Gemtuzumab ozogamicin in acute myeloid leukemia revisited.” (angol nyelven). Expert Opin Biol Ther., Ahead of print. o. DOI:10.1517/14712598.2014.922534. PMID24865510.
Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. (2012. October). „Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.” (angol nyelven). Blood.120 (16), 3187-205. o. DOI:10.1182/blood-2012-03-362608. PMID22879540.
Harrison CJ, Hills RK, Moorman AV, et al. (2010. June). „Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.” (angol nyelven). J Clin Oncol.28 (16), 2674-81. o. DOI:10.1200/JCO.2009.24.8997. PMID20439644.
von Neuhoff C, Reinhardt D, Sander A, et al. (2010. June). „Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.” (angol nyelven). J Clin Oncol.28 (16), 2682-9. o. DOI:10.1200/JCO.2009.25.6321. PMID20439630.
Pui CH, Howard SC. (2008. March). „Current management and challenges of malignant disease in the CNS in paediatric leukaemia.” (angol nyelven). Lancet Oncol.9 (3), 257-68. o. DOI:10.1016/S1470-2045(08)70070-6. PMID18308251.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. (2006). „Cancer statistics, 2006.” (angol nyelven). CA Cancer J Clin56 (2), 106-130. o. PMID16514137.
Deschler B, Lübbert M. (2006. November). „Acute myeloid leukemia: epidemiology and etiology.” (angol nyelven). Cancer.107 (9), 2099-107. o. PMID17019734.
Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C (1976). „Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group” (angol nyelven). Br J Haematol33 (4), 451–8. o. DOI:10.1111/j.1365-2141.1976.tb03563.x. PMID188440.
Duchayne E, Demur C, Rubie H, Robert A, Dastugue N. (1999. January). „Diagnosis of acute basophilic leukemia.” (angol nyelven). Leuk Lymphoma.32 (3-4), 269-78. o. PMID10037024.
Vardiman JW, Thiele J, Arber DA, "et al." (2009. July). „The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.” (angol nyelven). Blood.114 (5), 937-51.. o. DOI:10.1182/blood-2009-03-209262. PMID19357394.
Sanz G, Sanz M, Vallespí T, Cañizo M, Torrabadella M, García S, Irriguible D, San Miguel J (1989). „Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients.” (angol nyelven). Blood74 (1), 395–408. o. PMID2752119.
Le Beau M, Albain K, Larson R, Vardiman J, Davis E, Blough R, Golomb H, Rowley J (1986). „Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7” (angol nyelven). J Clin Oncol4 (3), 325–45. o. PMID3950675.
Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. (1986). „The incidence of secondary leukemias.” (angol nyelven). Haematologica.84 (10), 937-56. o. PMID10509043.
Wong O. (1995. June). „Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene.” (angol nyelven). Occup Environ Med.52 (6), 380-4. o. PMID7627314.
Irons RD, Chen Y, Wang X, Ryder J, Kerzic PJ. (2013. October). „Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease.” (angol nyelven). Genes Chromosomes Cancer.52 (10), 887-94. o. DOI:10.1002/gcc.22084. PMID23840003.
Bizzozero O, Johnson K, Ciocco A (1966). „Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. I. Distribution, incidence and appearance time” (angol nyelven). N Engl J Med274 (20), 1095–101. o. DOI:10.1056/NEJM196605192742001. PMID5932020.
Severson RK. (1987. July). „Cigarette smoking and leukemia.”. Cancer.60 (2), 141-4. o. PMID3474051.
Sandler DP, Shore DL, Anderson JR, et al. (1993. December). „Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.”. J Natl Cancer Inst.85 (24), 1994-2003. o. DOI:10.1093/jnci/85.24.1994. PMID8246285.
Varadarajan R, Licht AS, Hyland AJ, et al. (2012. March). „Smoking adversely affects survival in acute myeloid leukemia patients.”. Int J Cancer.130 (6), 1451-8. o. DOI:10.1002/ijc.26151. PMID21520043.
Shu XO, Ross JA, Pendergrass TW, et al. (1996. January). „Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study.”. J Natl Cancer Inst.88 (1), 24-31. o. DOI:10.1093/jnci/88.1.24. PMID8847721.
Bonnet D, Dick JE. (1997. July). „Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.” (angol nyelven). Nat Med.3 (7), 730-7. o. PMID9212098.
Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. (2002. July). „The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.” (angol nyelven). Nat Med.8 (7), 743-50. o. DOI:10.1038/nm726. PMID12091906.
Lo-Coco F, Avvisati G, et al. (2013. July). „Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.” (angol nyelven). N Engl J Med.369 (2), 111-21. o. DOI:10.1056/NEJMoa1300874. PMID23841729.
Ley TJ, Mardis ER, Ding L, et al. (2008. November). „DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.” (angol nyelven). Nature.456 (7218), 66-72. o. DOI:10.1038/nature07485. PMID18987736.
Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L. (1993. January). „Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.” (angol nyelven). Leukemia.7 (1), 2-9. o. PMID8418375.
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD; European LeukemiaNet. (2010. January). „Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.” (angol nyelven). Blood.115 (3), 453-74. o. DOI:10.1182/blood-2009-07-235358. PMID19880497.
Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N. (2006. January). „Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.” (angol nyelven). Br J Haematol.132 (2), 162-7. o. DOI:10.10.1111/j.1365-2141.2005.05853.x. PMID16398650.
Craig FE, Foon KA. (2008. April). „Flow cytometric immunophenotyping for hematologic neoplasms.” (angol nyelven). Blood.111 (8), 3941-67. o. DOI:10.1182/blood-2007-11-1205358. PMID18198345.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD. (2007. June). „Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.” (angol nyelven). Br J Haematol.137 (5), 387-400. o. DOI:10.1111/j.1365-2141.2007.06566.x. PMID17488484.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2002. July). „Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.” (angol nyelven). Blood.100 (1), 59-66. o. DOI:10.1182/blood.V100.1.59. PMID12070009.
Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2005. November). „No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.” (angol nyelven). Blood.106 (10), 3658-65. o. DOI:10.1182/blood-2005-03-1323. PMID16076872.
Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK. (2009. November). „Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.” (angol nyelven). Ann Hematol.88 (11), 1089-97. o. DOI:10.1007/s00277-009-0733-7. PMID19296110.
Ostronoff F, Estey E. (2013. September). „The role of quizartinib in the treatment of acute myeloid leukemia.” (angol nyelven). Expert Opin Investig Drugs.. DOI:110.1517/13543784.2013.842973. PMID24070241.
Paschka P, Marcucci G, Ruppert AS, Mrózek K, Chen H, Kittles RA, Vukosavljevic T, Perrotti D, Vardiman JW, Carroll AJ, Kolitz JE, Larson RA, Bloomfield CD; Cancer and Leukemia Group B. (2006. August). „Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.” (angol nyelven). J Clin Oncol.24 (24), 3904-11. o. DOI:10.1200/JCO.2006.06.9500. PMID16921041.
Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave P, Bennett JM, O'Connell MJ. (1988. April). „Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.” (angol nyelven). J Clin Oncol.6 (4), 583-7. o. PMID3282032.
Szczepański T, Orfão A, van der Velden VH, San Miguel JF, van Dongen JJ. (2001. July). „Minimal residual disease in leukaemia patients.” (angol nyelven). Lancet Oncol.2 (7), 409-17. o. PMID11905735.
Inoue D, Maruoka H, Takahashi T. (2010. August). „Clinical analysis and optimization of postremission therapy for acute myeloid leukemia patients with minimal residual disease as determined by flow cytometry.” (angol nyelven). Mediterr J Hematol Infect Dis.2 (2), e2010020. o. DOI:10.4084/MJHID.2010.020. PMID21415971.
Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z. (2012. August). „How to manage acute promyelocytic leukemia.” (angol nyelven). Leukemia.26 (8), 1743-51. o. DOI:10.1038/leu.2012.57. PMID22422168.
Lengfelder E, Hofmann WK, Nowak D. (2012. March). „Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.” (angol nyelven). Leukemia.26 (3), 433-42. o. DOI:10.1038/leu.2011.245. PMID22422168.
Larson RS, Tallman MS. (2003. September). „Retinoic acid syndrome: manifestations, pathogenesis, and treatment.” (angol nyelven). Best Pract Res Clin Haematol.16 (3), 453-61. o. PMID12935962.
Wang ZY, Chen Z. (2008. March). „Acute promyelocytic leukemia: from highly fatal to highly curable.” (angol nyelven). Blood.111 (5), 2505-15. o. DOI:10.1182/blood-2007-07-102798. PMID18299451.
Grimwade D, Mistry AR, Solomon E, Guidez F. (2010). „Acute promyelocytic leukemia: a paradigm for differentiation therapy.” (angol nyelven). Cancer Treat Res.145, 219-35. o. DOI:10.1007/978-0-387-69259-3_13. PMID20306254.
Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM, Tallman MS. (2011. August). „Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.” (angol nyelven). Blood.118 (5), 1248-54. o. DOI:10.1182/blood-2011-04-346437. PMID21653939.
Park Kwaan HC, Cull EH. (2014. March). „The coagulopathy in acute promyelocytic leukaemia - What have we learned in the past twenty years.” (angol nyelven). Best Pract Res Clin Haematol.27 (1), 11-18. o. DOI:10.1016/j.beha.2014.04.005. PMID24907013.
Elonen E, Almqvist A, et al. (1998. July). „Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group.” (angol nyelven). Leukemia.12 (7), 1041-8. o. PMID9665188.
Yanada M, Matsuo K, Emi N, Naoe T. (2005. April). „Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.” (angol nyelven). Cancer.103 (8), 1652-8. o. DOI:10.1002/cncr.20945. PMID15742336.
Koreth J, Schlenk R, et al. (2009. June). „Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.” (angol nyelven). JAMA.301 (22), 2349-61. o. DOI:10.1001/jama.2009.813. PMID19509382.
Vento S, Cainelli F. (2003. October). „Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment.” (angol nyelven). Lancet Oncol.4 (10), 595-604. o. PMID14554236.
Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, Paul M. (2007. December). „Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.” (angol nyelven). J Clin Oncol.25 (34), 5471-89. o. PMID17909198.
Gafter-Gvili A, Fraser A, Paul M, Leibovici L. (2005. June). „Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.” (angol nyelven). Ann Intern Med.142 (12), 979-95. o. PMID15968013.
Estey EH. (2001. March). „Growth factors in acute myeloid leukaemia.” (angol nyelven). Best Pract Res Clin Haematol.14 (1), 175-87. o. PMID11355930.
Shapira T, Pereg D, Lishner M. (2008. September). „How I treat acute and chronic leukemia in pregnancy.” (angol nyelven). Blood Rev.22 (5), 247-59. o. DOI:10.1016/j.blre.2008.03.006. PMID18472198.
Cardonick E, Iacobucci A. (2004. May). „Use of chemotherapy during human pregnancy.” (angol nyelven). Lancet Oncol.5 (5), 283-91. o. DOI:10.1016/S1470-2045(04)01466-4. PMID15120665.
Sievers EL, Larson RA, Stadtmauer EA, et al. (2001. July). „Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.” (angol nyelven). J Clin Oncol.19 (13), 3244-54. o. PMID11432892.
Giles FJ, Kantarjian HM, Kornblau SM, et al. (2001. July). „Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.” (angol nyelven). Cancer.92 (2), 406-13. o. PMID11466696.
Thol F, Schlenk RF. (2014. May). „Gemtuzumab ozogamicin in acute myeloid leukemia revisited.” (angol nyelven). Expert Opin Biol Ther., Ahead of print. o. DOI:10.1517/14712598.2014.922534. PMID24865510.
Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. (2012. October). „Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.” (angol nyelven). Blood.120 (16), 3187-205. o. DOI:10.1182/blood-2012-03-362608. PMID22879540.
Harrison CJ, Hills RK, Moorman AV, et al. (2010. June). „Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.” (angol nyelven). J Clin Oncol.28 (16), 2674-81. o. DOI:10.1200/JCO.2009.24.8997. PMID20439644.
von Neuhoff C, Reinhardt D, Sander A, et al. (2010. June). „Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.” (angol nyelven). J Clin Oncol.28 (16), 2682-9. o. DOI:10.1200/JCO.2009.25.6321. PMID20439630.
Pui CH, Howard SC. (2008. March). „Current management and challenges of malignant disease in the CNS in paediatric leukaemia.” (angol nyelven). Lancet Oncol.9 (3), 257-68. o. DOI:10.1016/S1470-2045(08)70070-6. PMID18308251.